Publications
2025
Scholarly publications
Hellamand, M., Moleman, T. E., Post, A. P., Mantel-Teeuwisse, A. K., Suleman, F., & Van Den Ham, H. A. (2025). Time to inclusion of selected medicines for priority diseases in National Essential Medicines Lists compared with the WHO Model List. BMJ Global Health, 10(6), Article e018550. [DOI] [Portal]
Costa, E., Del Grosso, V., Cappello, B., Genazzani, A. A., Huttner, B., Leufkens, H. G. M., Magrini, N., Nonino, F., Wirtz, V. J., van den Ham, H. A., & Moja, L. (2025). Medicines not recommended for inclusion in the who essential medicines list: a retrospective observational study. Frontiers in Medicine, 12, Article 1517020. [DOI] [Portal]
2024
Scholarly publications
Brinkhuis, F., Ruof, J., Ham, H. V. D., Gianfrate, F., Strammiello, V., Berntgen, M., Pavlovic, M., Mol, P. G. M., Wasem, J., Dyck, W. V., Cardone, A., Dierks, C., Schiel, A., Solà-Morales, O., Goettsch, W., & Julian, E. (2024). Evaluating progress towards implementation of the European HTA Regulation: Insights generated from the European Access Academy's multi-stakeholder survey. Health Policy and Technology, 13(5), Article 100930. [DOI] [Portal]
Brinkhuis, F., Julian, E., van den Ham, H., Gianfrate, F., Strammiello, V., Berntgen, M., Pavlovic, M., Mol, P., Wasem, J., Van Dyck, W., Cardone, A., Dierks, C., Schiel, A., Bernardini, R., Solà-Morales, O., Ruof, J., & Goettsch, W. (2024). Navigating the path towards successful implementation of the EU HTA Regulation: key takeaways from the 2023 Spring Convention of the European Access Academy. Health Research Policy and Systems, 22(1), Article 74. [DOI] [Portal]
Ooms, G. I., Usman, M. A., Reed, T., van den Ham, H. A., & Mantel-Teeuwisse, A. K. (2024). The impact of scheduling ketamine as an internationally controlled substance on anaesthesia care in Sub-Saharan Africa: a case study and key informant interviews. BMC Health Services Research, 24(1), Article 598. [DOI] [Repository]
Joosse, I. R., Mantel-Teeuwisse, A. K., Suleman, F., & van den Ham, H. A. (2024). Monitoring Access to Child Medicines: Introducing a Standardized Set of Age-Appropriate Medicines. Children, 11(3), Article 266. [DOI] [Repository]
Petro, E., Perumal-Pillay, V., Mantel-Teeuwisse, A. K., van den Ham, H. A., & Suleman, F. (2024). Evaluation of alignment of the reimbursement medicines list for children in Albania with the WHO essential medicines list for children. Journal of Pharmaceutical Policy and Practice, 17(1), 1-18. Article 2290100. [DOI] [Repository]
Joosse, I. R., van den Ham, H. A., Mantel-Teeuwisse, A. K., & Suleman, F. (2024). The caregiver’s experience of childhood cancer treatment in South Africa. Journal of Pharmaceutical Policy and Practice, 17(1), Article 2312382. [DOI] [Repository]
Costa, E., Moja, L., Wirtz, V. J., van den Ham, H. A., Huttner, B., Magrini, N., & Leufkens, H. G. (2024). Uptake of orphan drugs in the WHO essential medicines lists. Bulletin of the World Health Organization, 102(1), 22-31. [DOI] [Repository]
Professional publications
Hansen, J., Schackmann, L., van den Ham, R., Leonardo Alves, T., Moriarty, F., Geise, M., Hoebert, J., Mantel - Teeuwisse, A., Wilson, P., Kroneman, M., & van Dijk, L. (2024). Functioning of Directive 89/105/EEC relating to the transparency of measures regulating the prices and reimbursement of medicinal products (‘Transparency Directive’). European Union. https://op.europa.eu/en/publication-detail/-/publication/4f308379-762d-11ef-bbbe-01aa75ed71a1/language-en [Portal]
2023
Scholarly publications
Costa, E., Girotti, S., van den Ham, H. A., Cipolli, M., van der Ent, C. K., Taylor-Cousar, J. L., & Leufkens, H. G. M. (2023). Traits, trends and hits of orphan drug designations in cystic fibrosis. Journal of Cystic Fibrosis, 22(5), 949-957. [DOI] [Repository]
Joosse, I. R., Tordrup, D., Glanville, J., Mantel-Teeuwisse, A. K., & van den Ham, H. A. (2023). A systematic review of policies regulating or removing mark-ups in the pharmaceutical supply and distribution chain. Health Policy, 138, 1-9. Article 104919. [DOI] [Repository]
Joosse, I. R., Van Den Ham, H. A., Mantel-Teeuwisse, A. K., & Suleman, F. (2023). Alignment in the registration, selection, procurement and reimbursement of essential medicines for childhood cancers in South Africa. BMJ Global Health, 8(9), Article e012309. [DOI] [Repository]
Ooms, G. I., van Oirschot, J., de Kant, D., van den Ham, H. A., Mantel-Teeuwisse, A. K., & Reed, T. (2023). Barriers to accessing internationally controlled essential medicines in sub-saharan Africa: A scoping review. International Journal of Drug Policy, 118, Article 104078. [DOI] [Repository]
Joosse, I. R., Mantel-Teeuwisse, A. K., Suleman, F., & van den Ham, H. A. (2023). Sustainable Development Goal indicator for measuring availability and affordability of medicines for children: a proof-of-concept study. BMJ Open, 13(4), Article e065929. [DOI] [Repository]
Kusynová, Z., van den Ham, H. A., Leufkens, H. G. M., & Mantel-Teeuwisse, A. K. (2023). Pharmaceutical Scientists' Perspectives on Capacity Building in Pharmaceutical Sciences. Journal of Pharmaceutical Sciences, 112(7), 1997-2003. [DOI] [Repository]
Kusynová, Z., Bais, Y., van den Ham, H. A., Mantel-Teeuwisse, A. K., Etame-Loe, G., Kaale, E., Sarr, S. O., Guiet-Mati, F., & Bourdillon-Esteve, P. (2023). Improved knowledge on substandard and falsified (SF) medical products through a dedicated course for pharmacy students at three universities in sub-Saharan Africa. BMJ Global Health, 6(3 S), Article e009367. [DOI] [Repository]
Joosse, I. R., Wirtz, V. J., van Mourik, A. T., Wagner, B. A., Mantel-Teeuwisse, A. K., Suleman, F., & van den Ham, H. A. (2023). SDG indicator 3.b.3 - an analysis of its robustness and challenges for measuring access to medicines for children. BMC Health Services Research, 23(1), Article 574. [DOI] [Repository]
Joosse, I. R., Tordrup, D., Glanville, J., Kotas, E., Mantel-Teeuwisse, A. K., & van den Ham, H. A. (2023). Evidence on the effectiveness of policies promoting price transparency -: A systematic review. Health Policy, 134, Article 104681. [DOI] [Repository]
Joosse, I. R., Tordrup, D., Bero, L., Mantel-Teeuwisse, A. K., & van den Ham, H. A. (2023). A critical review of methodologies used in pharmaceutical pricing policy analyses. Health Policy, 134, Article 104576. [DOI] [Repository]
2022
Scholarly publications
Joosse, I. R., Mantel-Teeuwisse, A. K., Wirtz, V. J., Suleman, F., & van den Ham, H. A. (2022). Missing data on accessibility of children's medicines. Bulletin of the World Health Organization, 100(10), 636-642. [DOI] [Repository]
Ooms, G. I., van Oirschot, J., Okemo, D., Reed, T., van den Ham, H. A., & Mantel-Teeuwisse, A. K. (2022). Healthcare workers’ perspectives on access to sexual and reproductive health services in the public, private and private not-for-profit sectors: insights from Kenya, Tanzania, Uganda and Zambia. BMC Health Services Research, 22(1), 1-11. Article 873. [DOI] [Repository]
Kusynová, Z., van den Ham, H. A., Leufkens, H. G. M., & Mantel-Teeuwisse, A. K. (2022). Longitudinal study of Good Pharmacy Practice roles covered at the annual world pharmacy congresses 2003–2019. Journal of Pharmaceutical Policy and Practice, 15(1), 1-14. Article 94. [DOI] [Repository]
van den Dries, C. J., Pajouheshnia, R., van den Ham, H. A., Souverein, P., Moons, K. G. M., Hoes, A. W., Geersing, G. J., & van Doorn, S. (2022). Safety of off-label dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. British Journal of Clinical Pharmacology, 89(2), 751-761. [DOI] [Repository]
Perehudoff, K., Kibira, D., Wuyts, E., Pericas, C., Omwoha, J., van den Ham, H. A., Mantel-Teeuwisse, A. K., & Michielsen, K. (2022). A comparative human rights analysis of laws and policies for adolescent contraception in Uganda and Kenya. Reproductive Health, 19(1), 1-14. Article 37. [DOI] [Repository]
Kusynová, Z., Pauletti, G. M., van den Ham, H. A., Leufkens, H. G. M., & Mantel-Teeuwisse, A. K. (2022). Unmet medical need as a driver for pharmaceutical sciences - a survey among scientists. Journal of Pharmaceutical Sciences, 111, 1318-1324. [DOI] [Repository]
2021
Scholarly publications
Kusynová, Z., Kicken, M., van den Ham, H. A., & Mantel-Teeuwisse, A. K. (2021). Identifying the teaching content on substandard and falsified medical products in global pharmacy education as critical public health issue. Pharmacy Education, 21, 504-516. [DOI] [Repository]
Vogler, S., Haasis, M. A., van den Ham, R., Humbert, T., Garner, S., & Suleman, F. (2021). European collaborations on medicine and vaccine procurement. Bulletin of the World Health Organization, 99(10), 715-721. [DOI] [Repository]
Ooms, G. I., van Oirschot, J., Waldmann, B., Okemo, D., Mantel-Teeuwisse, A. K., van den Ham, H. A., & Reed, T. (2021). The burden of snakebite in rural communities in Kenya: A household survey. American Journal of Tropical Medicine and Hygiene, 105(3), 828-836. [DOI] [Repository]
Kibira, D., Asiimwe, C., Muwonge, M., van den Ham, H. A., Reed, T., Leufkens, H. G., & Mantel-Teeuwisse, A. K. (2021). Donor Commitments and Disbursements for Sexual and Reproductive Health Aid in Kenya, Tanzania, Uganda and Zambia. Frontiers in Public Health, 9, 1-12. Article 645499. [DOI] [Repository]
Ooms, G. I., van Oirschot, J., Okemo, D., Waldmann, B., Erulu, E., Mantel-Teeuwisse, A. K., van den Ham, H. A., & Reed, T. (2021). Availability, affordability and stock-outs of commodities for the treatment of snakebite in kenya. PLoS Neglected Tropical Diseases, 15(8), 1-20. Article e0009702. [DOI] [Repository]
van den Ham, H. A., Souverein, P. C., Klungel, O. H., Platt, R. W., Ernst, P., Dell'Aniello, S., Schmiedl, S., Grave, B., Rottenkolber, M., Huerta, C., Martín Merino, E., León-Muñoz, L. M., Montero, D., Andersen, M., Aakjær, M., De Bruin, M. L., & Gardarsdottir, H. (2021). Major bleeding in users of direct oral anticoagulants in atrial fibrillation: A pooled analysis of results from multiple population-based cohort studies. Pharmacoepidemiology and Drug Safety, 30(10), 1339-1352. [DOI] [Repository]
Kibira, D., Ooms, G. I., Van Den Ham, H. A., Namugambe, J. S., Reed, T., Leufkens, H. G. M., & Mantel-Teeuwisse, A. (2021). Access to oxytocin and misoprostol for management of postpartum haemorrhage in Kenya, Uganda and Zambia: A cross-sectional assessment of availability, prices and affordability. BMJ Open, 11(1), 1-8. Article e042948. [DOI] [Repository]
Kibira, D., Ssebagereka, A., van den Ham, H. A., Opigo, J., Katamba, H., Seru, M., Reed, T., Leufkens, H. G., & Mantel-Teeuwisse, A. K. (2021). Trends in access to anti‐malarial treatment in the formal private sector in Uganda: an assessment of availability and affordability of first‐line anti‐malarials and diagnostics between 2007 and 2018. Malaria Journal, 20(1), 1-8. Article 142. [DOI] [Repository]
Ooms, G. I., van Oirschot, J., Waldmann, B., von Bernus, S., van den Ham, H. A., Mantel-Teeuwisse, A. K., & Reed, T. (2021). The Current State of Snakebite Care in Kenya, Uganda, and Zambia: Healthcare Workers' Perspectives and Knowledge, and Health Facilities' Treatment Capacity. American Journal of Tropical Medicine and Hygiene, 104(2), 774–782. [DOI] [Repository]
Rustem Gulluoglu, F., Souverein, P. C., van den Ham, H. A., de Boer, A., & Komen, J. (2021). Comparative effectiveness and safety of direct oral anticoagulants versus warfarin in UK patients with atrial fibrillation and type 2 diabetes: a retrospective cohort study. Pharmacoepidemiology and Drug Safety, 30(10), 1293-1320. [DOI] [Repository]
PE, PV consortium H. Gardarsdottir (2021). Prescribers' compliance with Summary of Product Characteristics of dabigatran, rivaroxaban and apixaban - a European comparative drug utilization study. Basic & Clinical Pharmacology & Toxicology, 128(3), 440-454. [DOI] [Repository]
Souverein, P. C., van den Ham, H. A., Huerta, C., Merino, E. M., Montero, D., León-Muñoz, L. M., Schmiedl, S., Heeke, A., Rottenkolber, M., Andersen, M., Aakjaer, M., De Bruin, M. L., Klungel, O. H., & Gardarsdottir, H. (2021). Comparing risk of major bleeding between users of different oral anticoagulants in patients with nonvalvular atrial fibrillation. British Journal of Clinical Pharmacology, 87(3), 988-1000. [DOI] [Repository]
2020
Scholarly publications
Tordrup, D., van den Ham, R., Leopold, C., Glanville, J., Kotas, E., & Mantel - Teeuwisse, A. (2020). Web Annex A: Systematic reviews for the update of the WHO Guideline on country pharmaceutical pricing policies. In WHO guideline on country pharmaceutical pricing policies World Health Organization. http://ncbi.nlm.nih.gov/books/NBK570141/
van den Dries, C. J., van Doorn, S., Souverein, P., Pajouheshnia, R., Moons, K. G. M., Hoes, A. W., Geersing, G.-J., & van den Ham, H. A. (2020). The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation. TH Open: Companion Journal to Thrombosis and Haemostasis, 4(4), e417-e426. [DOI] [Repository]
Ooms, G. I., Kibira, D., Reed, T., Van Den Ham, H. A., Mantel-Teeuwisse, A. K., & Buckland-Merrett, G. (2020). Access to sexual and reproductive health commodities in East and Southern Africa: A cross-country comparison of availability, affordability and stock-outs in Kenya, Tanzania, Uganda and Zambia. BMC Public Health, 20(1), Article 1053. [DOI] [Repository]
Tordrup, D., Van Den Ham, H. A., Glanville, J., & Mantel-Teeuwisse, A. K. (2020). Systematic reviews of ten pharmaceutical pricing policies - A research protocol. Journal of Pharmaceutical Policy and Practice, 13(1), Article 22. [DOI] [Repository]
Zhang, Y., Souverein, P. C., Gardarsdottir, H., van den Ham, H. A., Maitland-van der Zee, A. H., & de Boer, A. (2020). Risk of major bleeding among users of direct oral anticoagulants combined with interacting drugs: a population-based nested case-control study. British Journal of Clinical Pharmacology, 86(6), 1150-1164. [DOI] [Repository]
2019
Scholarly publications
van den Ham, H., Souverein, P., Klungel, O., Platt, R., Ernst, P., Dell'Aniello, S., Schmiedl, S., Grave, B., Rottenkolber, M., Huerta, C., Merino, E. M., Leon-Munoz, L., Montero, D., Andersen, M., Aakjaer, M., Bruin, M. L. D., & Gardarsdottir, H. (2019). Risk of major bleeding associated with the use of individual direct oral anticoagulants compared to vitamin K antagonists in patients with non-valvular atrial fibrillation: A metaanalysis of results from multiple population based cohort studies using a common protocol in Europe and Canada. Pharmacoepidemiology and Drug Safety, 28(S2). [DOI]
Souverein, P. C., Van Den Ham, H. A., Huerta, C., Merino, E. M., Montero, D., León-Muñoz, L. M., Schmiedl, S., Rottenkolber, M., Andersen, M., Aakjær, M., De Bruin, M. L., Klungel, O. H., & Gardarsdottir, H. (2019). Risk of major bleeding associated with the use of direct oral anticoagulants compared to vitamin K antagonists in patients with atrial fibrillation: A European multicountry population-based cohort study. Pharmacoepidemiology and Drug Safety, 28(S2), 553-553. [DOI]
Van Den Ham, H., Souverein, P., Klungel, O., Platt, R., Ernst, P., Dell'Aniello, S., Schmiedl, S., Grave, B., Rottenkolber, M., Huerta, C., Merino, E. M., León-Muñoz, L., Montero, D., Andersen, M., Aakjær, M., De Bruin, M., & Gardarsdottir, H. (2019). Risk of major bleeding associated with the use of individual direct oral anticoagulants compared to vitamin K antagonists in patients with non-valvular atrial fibrillation: A metaanalysis of results from multiple population based cohort studies using a common protocol in Europe and Canada. Pharmacoepidemiology and Drug Safety, 28(S2), 410-411. [DOI]
Rottenkolber, M., Schmiedl, S., Ibanez, L., Sabaté, M., Ballarín, E., Vidal, X., Leon-Munoz, L. M., Huerta, C., Martin Merino, E., Montero, D., Gasse, C., Andersen, M., Aakjær, M., De Bruin, M. L., Gerlach, R., Tauscher, M., Souverein, P. C., Van Den Ham, R., Klungel, O., & Gardarsdottir, H. (2019). Prescribers' compliance with SmPC recommendations for dabigatran, rivaroxaban, and Apixaban: A European comparative drug utilization study. Pharmacoepidemiology and Drug Safety, 28(S2), 148-149. [DOI]
Ibanez, L., Sabaté, M., Vidal, X., Ballarín, E., Rottenkolber, M., Schmiedl, S., Heeke, A., Huerta, C., Merino, E. M., Montero, D., Leon-Muñoz, L. M., Gasse, C., Moore, N., Droz, C., Lassalle, R., Aakjaer, M., Andersen, M., De Bruin, M. L., Groenwold, R., ... Gardarsdottir, H. (2019). Incidence of direct oral anticoagulation use for non valvular atrial fibrillation and characteristics of users in six European countries (2008-2015): A cross-national drug utilization study. Pharmacoepidemiology and Drug Safety, 28(S2), 397. [DOI]
Jacobs, T. G., Robertson, J., van den Ham, H. A., Iwamoto, K., Bak Pedersen, H., & Mantel-Teeuwisse, A. K. (2019). Assessing the impact of law enforcement to reduce over-the-counter (OTC) sales of antibiotics in low- and middle-income countries; a systematic literature review. BMC Health Services Research, 19(1), Article 536. [DOI] [Repository]
Sabaté Gallego, M., Ibáñez Mora, L., Vidal Guitart, X., Ballarin Alins, E., Rottenkolber, M., Schmiedl, S., Heeke, A., Huerta, C., Martin Merino, E., Montero, D., León-Muñoz, L. M., Gasse, C., Moore, N., Droz, C., Lassalle, R., Aakjaer, M., Andersen, M., De Briun, M., Groenwold, R., ... Gardarsdottir, H. (2019). Adherence to direct oral anticoagulants in patients with non-valvular atrial fibrillation cross-national comparison in six european countries. European Journal of Clinical Pharmacology, 75, 27-28. [DOI]
Ibáñez, L., Sabaté, M., Vidal, X., Ballarin, E., Rottenkolber, M., Schmiedl, S., Heeke, A., Huerta, C., Martin Merino, E., Montero, D., Leon-Muñoz, L. M., Gasse, C., Moore, N., Droz, C., Lassalle, R., Aakjær, M., Andersen, M., De Bruin, M. L., Groenwold, R., ... Gardarsdottir, H. (2019). Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008–2015): A cross-national drug utilization study. British Journal of Clinical Pharmacology, 85(11), 2524-2539. [DOI] [Repository]
2018
Scholarly publications
Iyengar, S., van den Ham, R., & Suleman, F. (2018). Medicine Prices in Africa. In Medicine Price Surveys, Analyses and Comparisons: Evidence and Methodology Guidance (pp. 85-111). Elsevier. [DOI]
Zhang, Y., De Boer, A., Gardarsdottir, H., Van Den Ham, H. A., Maitland-Van Der Zee, A. H., & Souverein, P. C. (2018). Concurrent use of DOACs and pharmacodynamic interacting drugs is associated with an increased risk of major bleeding compared with patients using DOACs alone: Nested case-control study in UK CPRD. Pharmacoepidemiology and Drug Safety, 27, 465-466. [DOI] [Repository]
2017
Scholarly publications
Gieling, E., van den Ham, H. A., van Onzenoort, H., Bos, J., Kramers, C., de Boer, A., de Vries, F., & Burden, A. M. (2017). Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study: a cohort study. British Journal of Clinical Pharmacology, 83(8), 1844-1859. [DOI] [Repository]
2016
Scholarly publications
Van Den Ham, R. (2016). Individuele baten-risicobalans zinvol voor preventie beroerte. Pharmaceutisch Weekblad, 151(50), 14-15.
Van Den Ham, H. A., Klungel, O. H., Singer, D. E., Leufkens, H. G. M., & Van Staa, T. P. (2016). Reply Comparing the ATRIA, CHADS2, and CHA2DS2-VASc Scores for Stroke Prediction in Atrial Fibrillation. Journal of the American College of Cardiology, 67(19), 2317-2318. [DOI] [Repository]
van den Ham, H. A. (2016). Benefits and risks for the individual, anticoagulation for patients with atrial fibrillation. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. [Repository]
Klungel, O. H., Kurz, X., de Groot, M. C. H., Schlienger, R. G., Tcherny-Lessenot, S., Grimaldi, L., Ibáñez, L., Groenwold, R. H. H., Reynolds, R. F., Alvarez, Y., Candore, G., Durand, J., Slattery, J., Hasford, J., Rottenkolber, M., Schmiedl, S., de Abajo Iglesias, F., Gil, M., Gonzalez, R., ... On behalf of the members of work-package 2 of PROTECT (2016). Multi-centre, multi-database studies with common protocols: Lessons learnt from the IMI PROTECT project. Pharmacoepidemiology and Drug Safety, 25(supplement S1), 156-165. [DOI] [Repository]
2015
Scholarly publications
van den Ham, H. A., Klungel, O. H., Singer, D. E., Leufkens, H. G. M., & van Staa, T. P. (2015). Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care Database. Journal of the American College of Cardiology, 66(17), 1851-9. [DOI] [Repository]
2014
Scholarly publications
Hallgreen, C. E., van den Ham, H. A., Mt-Isa, S., Ashworth, S., Hermann, R., Hobbiger, S., Luciani, D., Micaleff, A., Thomson, A., Wang, N., van Staa, T. P., Downey, G., Hirsch, I., Hockley, K., Juhaeri, J., Metcalf, M., Mwangi, J., Nixon, R., Peters, R., ... Wise, L. (2014). Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology. Pharmacoepidemiology and Drug Safety, 23(9), 974-983. [DOI]
Other output
Van Den Ham, H. A., Klungel, O. H., Singer, D. E., Leufkens, H. G. M., & Van Staa, T. P. (2014). Comparison of ATRIA and CHA2DS2-VASc risk stratification schemes for the prediction of stroke in the individual patient with atrial fibrillation and the impact on treatment decisions. European Heart Journal, 35(S1), 1032. Article 5833 . [DOI] [Repository]
Van Den Ham, H. A., Klungel, O. H., Singer, D. E., Leufkens, H. G. M., & Van Staa, T. P. (2014). Comparison of atria and CHA2DS2-vasc risk stratification schemes for the prediction of stroke in the individual patient with atrial fibrillation and the impact on treatment decisions. Pharmacoepidemiology and Drug Safety, 23(S1), 359-360. Article 672. [DOI] [Repository]
2013
Scholarly publications
van den Ham, H. A., Klungel, O. H., Leufkens, H. G. M., & van Staa, T. P. (2013). The patterns of anticoagulation control and the risk of stroke, bleeding and mortality in patients with non-valvular atrial fibrillation. Journal of Thrombosis and Haemostasis, 11(1), 107-15.
2010
Scholarly publications
Van Den Ham, R. (2010). Slechts een keer per half jaar injectie nodig: Gebruiksgemak maakt denosumab veelbelovend. Pharmaceutisch Weekblad, 145(48), 30-33.